News
Brand Change Announcement: AegirBio AB has officially changed its name to Magnasense AB. The new website, www.magnasense.com, launched on 9 July 2024, with redirects from www.aegirbio.com.
Aegirbio is a precision medicine company focused on therapeutic drug monitoring of biologic therapies.
Learn more about MoNATor – the first assay to measure the level of natalizumab circulating in blood. This information may help optimize treatment intervals, potentially reducing PML risk.
Physician flyer (pdf)
Information for Healthcare Providers
ACTRIMS 2019 poster (ppt)
MoNATor Test for Therapeutic Drug Monitoring of Natalizumab in Multiple Sclerosis Patients (PPT)
Interested in moNATor?
Come visit our Booth #320 or contact us for details: info@aegirbio.com